Table 5. Flap and systemic complications.
| Variable | TIVA group (n=31) | Sevo group (n=52) | P value |
|---|---|---|---|
| Flap compromise | 2 (6.5%) | 5 (9.6%) | 0.707 |
| Flap arterial thrombosis | 0 (0.0%) | 0 (0.0%) | 1.000 |
| Flap venous thrombosis | 1 (3.2%) | 0 (0.0%) | 0.373 |
| Mechanical obstruction | 1 (3.2%) | 5 (9.6%) | 0.403 |
| Partial flap loss | 0 (0.0%) | 0 (0.0%) | 1.000 |
| Total flap loss | 1 (3.2%) | 0 (0.0%) | 0.373 |
| Wound infection | 0 (0.0%) | 1 (1.9%) | 1.000 |
| Delayed wound healing | 0 (0.0%) | 1 (1.9%) | 1.000 |
| Wound breakdown | 0 (0.0%) | 0 (0.0%) | 1.000 |
| Systemic complications | 0 (0.0%) | 1 (1.9%) | 1.000 |
Systemic complications included deep vein thrombosis, pulmonary embolism, stroke, arrhythmia, myocardial infarction, pleural effusion, pneumonia, renal insufficiency, and others. TIVA, total intravenous anesthesia; Sevo, sevoflurane.